Qualified partnership enquiry

Contact AXELYUM MEDTECH

For industrial transfer, licensing, co-development or strategic partnership discussions regarding PERFU+3. Detailed documentation is available under NDA.

Send an enquiry

For qualified professional enquiries only. PERFU+3 is not a consumer product — it is a protected technology platform prepared for industrial evaluation.

By submitting this form, you agree that AXELYUM MEDTECH may process the information provided to respond to your enquiry. Please do not submit confidential information before a suitable NDA is in place.

Company contact

AXELYUM MEDTECH SASU SIREN 105 779 011
SIRET 105 779 011 00011
Les Aqueducs – Bâtiment 3
535 Route des Lucioles
06560 Valbonne — France
Luc Pichotte Président & Fondateur — AXELYUM MEDTECH SASU
Focus Industrial transfer · Licensing · Strategic MedTech partnerships

Before contacting us

  • PERFU+3 is a protected technology platform — not a commercial product.
  • Detailed technical documentation requires an NDA.
  • Industrial, strategic and regulatory discussions are welcome.
ⓘ  FDA Pre-Submission interaction initiated under Q261504. This does not constitute FDA clearance or market authorisation.